Crispr Therapeutics AG
Records under this name other than the patents Crispr Therapeutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 76 patents it holds.
Back to Crispr Therapeutics AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,129,471 | Materials and Methods for Treatment of Human Genetic Diseases Including Hemoglobinopathies Formerly held In force · High confidence | In force | High confidence | |
| US 10,738,305 | Materials and Methods for Treatment of Hemoglobinopathies Formerly held In force · High confidence | In force | High confidence | |
| US 12,053,531 | Materials and Methods for Treatment of Duchenne Muscular Dystrophy Formerly held In force · High confidence | In force | High confidence | |
| US 12,442,020 | Materials and Methods for Treatment of Pain Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 12,134,767 | Materials and Methods for Treatment of Hemoglobinopathies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,369,692 | Materials and Methods for Treatment of Duchenne Muscular Dystrophy Formerly held In force · High confidence | In force | High confidence | |
| US 11,801,313 | Materials and Methods for Treatment of Pain Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,662,425 | Materials and Methods for Treatment of Autosomal Dominant Retinitis Pigmentosa Formerly held In force · High confidence | In force | High confidence | |
| US 12,247,201 | Materials and Methods for Treatment of Autosomal Dominant Retinitis Pigmentosa Formerly held In force · High confidence | In force | High confidence | |
| US 10,995,328 | Materials and Methods for Treatment of Autosomal Dominant Cone-Rod Dystrophy Formerly held In force · High confidence | In force | High confidence |